世界の高移動度群タンパク質B1市場インサイト及び予測(~2026年)

【英語タイトル】Global High Mobility Group Protein B1 Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV01191)・商品コード:QYR20NV01191
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは高移動度群タンパク質B1の世界市場について調査・分析した資料です。種類別(ドシパルスタットナトリウム、RBM-005、EV-007156、その他)の市場規模、用途別(自己免疫疾患、脳梗塞、化学療法効果、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別高移動度群タンパク質B1の競争状況、市場シェア
・世界の高移動度群タンパク質B1市場:種類別市場規模 2015年-2020年(ドシパルスタットナトリウム、RBM-005、EV-007156、その他)
・世界の高移動度群タンパク質B1市場:種類別市場規模予測 2021年-2026年(ドシパルスタットナトリウム、RBM-005、EV-007156、その他)
・世界の高移動度群タンパク質B1市場:用途別市場規模 2015年-2020年(自己免疫疾患、脳梗塞、化学療法効果、その他)
・世界の高移動度群タンパク質B1市場:用途別市場規模予測 2021年-2026年(自己免疫疾患、脳梗塞、化学療法効果、その他)
・北米の高移動度群タンパク質B1市場分析:米国、カナダ
・ヨーロッパの高移動度群タンパク質B1市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの高移動度群タンパク質B1市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の高移動度群タンパク質B1市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの高移動度群タンパク質B1市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Affibody AB、Cantex Pharmaceuticals Inc、Dicerna Pharmaceuticals Inc、Evec Inc、Ribomic Inc
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global High Mobility Group Protein B1 Market
The global High Mobility Group Protein B1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global High Mobility Group Protein B1 Scope and Market Size
High Mobility Group Protein B1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Mobility Group Protein B1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the High Mobility Group Protein B1 market is segmented into
Dociparstat Sodium
RBM-005
EV-007156
Others

Segment by Application, the High Mobility Group Protein B1 market is segmented into
Autoimmune Disorders
Cerebral Infarction
Chemotherapy Effects
Others

Regional and Country-level Analysis
The High Mobility Group Protein B1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the High Mobility Group Protein B1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and High Mobility Group Protein B1 Market Share Analysis
High Mobility Group Protein B1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in High Mobility Group Protein B1 business, the date to enter into the High Mobility Group Protein B1 market, High Mobility Group Protein B1 product introduction, recent developments, etc.

The major vendors covered:
Affibody AB
Cantex Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Evec Inc
Ribomic Inc

【レポートの目次】

1 Study Coverage
1.1 High Mobility Group Protein B1 Product Introduction
1.2 Market Segments
1.3 Key High Mobility Group Protein B1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global High Mobility Group Protein B1 Market Size Growth Rate by Type
1.4.2 Dociparstat Sodium
1.4.3 RBM-005
1.4.4 EV-007156
1.4.5 Others
1.5 Market by Application
1.5.1 Global High Mobility Group Protein B1 Market Size Growth Rate by Application
1.5.2 Autoimmune Disorders
1.5.3 Cerebral Infarction
1.5.4 Chemotherapy Effects
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global High Mobility Group Protein B1 Market Size, Estimates and Forecasts
2.1.1 Global High Mobility Group Protein B1 Revenue 2015-2026
2.1.2 Global High Mobility Group Protein B1 Sales 2015-2026
2.2 Global High Mobility Group Protein B1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global High Mobility Group Protein B1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global High Mobility Group Protein B1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global High Mobility Group Protein B1 Competitor Landscape by Players
3.1 High Mobility Group Protein B1 Sales by Manufacturers
3.1.1 High Mobility Group Protein B1 Sales by Manufacturers (2015-2020)
3.1.2 High Mobility Group Protein B1 Sales Market Share by Manufacturers (2015-2020)
3.2 High Mobility Group Protein B1 Revenue by Manufacturers
3.2.1 High Mobility Group Protein B1 Revenue by Manufacturers (2015-2020)
3.2.2 High Mobility Group Protein B1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global High Mobility Group Protein B1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by High Mobility Group Protein B1 Revenue in 2019
3.2.5 Global High Mobility Group Protein B1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 High Mobility Group Protein B1 Price by Manufacturers
3.4 High Mobility Group Protein B1 Manufacturing Base Distribution, Product Types
3.4.1 High Mobility Group Protein B1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers High Mobility Group Protein B1 Product Type
3.4.3 Date of International Manufacturers Enter into High Mobility Group Protein B1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global High Mobility Group Protein B1 Market Size by Type (2015-2020)
4.1.1 Global High Mobility Group Protein B1 Sales by Type (2015-2020)
4.1.2 Global High Mobility Group Protein B1 Revenue by Type (2015-2020)
4.1.3 High Mobility Group Protein B1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global High Mobility Group Protein B1 Market Size Forecast by Type (2021-2026)
4.2.1 Global High Mobility Group Protein B1 Sales Forecast by Type (2021-2026)
4.2.2 Global High Mobility Group Protein B1 Revenue Forecast by Type (2021-2026)
4.2.3 High Mobility Group Protein B1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global High Mobility Group Protein B1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global High Mobility Group Protein B1 Market Size by Application (2015-2020)
5.1.1 Global High Mobility Group Protein B1 Sales by Application (2015-2020)
5.1.2 Global High Mobility Group Protein B1 Revenue by Application (2015-2020)
5.1.3 High Mobility Group Protein B1 Price by Application (2015-2020)
5.2 High Mobility Group Protein B1 Market Size Forecast by Application (2021-2026)
5.2.1 Global High Mobility Group Protein B1 Sales Forecast by Application (2021-2026)
5.2.2 Global High Mobility Group Protein B1 Revenue Forecast by Application (2021-2026)
5.2.3 Global High Mobility Group Protein B1 Price Forecast by Application (2021-2026)

6 North America
6.1 North America High Mobility Group Protein B1 by Country
6.1.1 North America High Mobility Group Protein B1 Sales by Country
6.1.2 North America High Mobility Group Protein B1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America High Mobility Group Protein B1 Market Facts & Figures by Type
6.3 North America High Mobility Group Protein B1 Market Facts & Figures by Application

7 Europe
7.1 Europe High Mobility Group Protein B1 by Country
7.1.1 Europe High Mobility Group Protein B1 Sales by Country
7.1.2 Europe High Mobility Group Protein B1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe High Mobility Group Protein B1 Market Facts & Figures by Type
7.3 Europe High Mobility Group Protein B1 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific High Mobility Group Protein B1 by Region
8.1.1 Asia Pacific High Mobility Group Protein B1 Sales by Region
8.1.2 Asia Pacific High Mobility Group Protein B1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific High Mobility Group Protein B1 Market Facts & Figures by Type
8.3 Asia Pacific High Mobility Group Protein B1 Market Facts & Figures by Application

9 Latin America
9.1 Latin America High Mobility Group Protein B1 by Country
9.1.1 Latin America High Mobility Group Protein B1 Sales by Country
9.1.2 Latin America High Mobility Group Protein B1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America High Mobility Group Protein B1 Market Facts & Figures by Type
9.3 Central & South America High Mobility Group Protein B1 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa High Mobility Group Protein B1 by Country
10.1.1 Middle East and Africa High Mobility Group Protein B1 Sales by Country
10.1.2 Middle East and Africa High Mobility Group Protein B1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa High Mobility Group Protein B1 Market Facts & Figures by Type
10.3 Middle East and Africa High Mobility Group Protein B1 Market Facts & Figures by Application

11 Company Profiles
11.1 Affibody AB
11.1.1 Affibody AB Corporation Information
11.1.2 Affibody AB Description and Business Overview
11.1.3 Affibody AB Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Affibody AB High Mobility Group Protein B1 Products Offered
11.1.5 Affibody AB Related Developments
11.2 Cantex Pharmaceuticals Inc
11.2.1 Cantex Pharmaceuticals Inc Corporation Information
11.2.2 Cantex Pharmaceuticals Inc Description and Business Overview
11.2.3 Cantex Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cantex Pharmaceuticals Inc High Mobility Group Protein B1 Products Offered
11.2.5 Cantex Pharmaceuticals Inc Related Developments
11.3 Dicerna Pharmaceuticals Inc
11.3.1 Dicerna Pharmaceuticals Inc Corporation Information
11.3.2 Dicerna Pharmaceuticals Inc Description and Business Overview
11.3.3 Dicerna Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Dicerna Pharmaceuticals Inc High Mobility Group Protein B1 Products Offered
11.3.5 Dicerna Pharmaceuticals Inc Related Developments
11.4 Evec Inc
11.4.1 Evec Inc Corporation Information
11.4.2 Evec Inc Description and Business Overview
11.4.3 Evec Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Evec Inc High Mobility Group Protein B1 Products Offered
11.4.5 Evec Inc Related Developments
11.5 Ribomic Inc
11.5.1 Ribomic Inc Corporation Information
11.5.2 Ribomic Inc Description and Business Overview
11.5.3 Ribomic Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ribomic Inc High Mobility Group Protein B1 Products Offered
11.5.5 Ribomic Inc Related Developments
11.1 Affibody AB
11.1.1 Affibody AB Corporation Information
11.1.2 Affibody AB Description and Business Overview
11.1.3 Affibody AB Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Affibody AB High Mobility Group Protein B1 Products Offered
11.1.5 Affibody AB Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 High Mobility Group Protein B1 Market Estimates and Projections by Region
12.1.1 Global High Mobility Group Protein B1 Sales Forecast by Regions 2021-2026
12.1.2 Global High Mobility Group Protein B1 Revenue Forecast by Regions 2021-2026
12.2 North America High Mobility Group Protein B1 Market Size Forecast (2021-2026)
12.2.1 North America: High Mobility Group Protein B1 Sales Forecast (2021-2026)
12.2.2 North America: High Mobility Group Protein B1 Revenue Forecast (2021-2026)
12.2.3 North America: High Mobility Group Protein B1 Market Size Forecast by Country (2021-2026)
12.3 Europe High Mobility Group Protein B1 Market Size Forecast (2021-2026)
12.3.1 Europe: High Mobility Group Protein B1 Sales Forecast (2021-2026)
12.3.2 Europe: High Mobility Group Protein B1 Revenue Forecast (2021-2026)
12.3.3 Europe: High Mobility Group Protein B1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific High Mobility Group Protein B1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: High Mobility Group Protein B1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: High Mobility Group Protein B1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: High Mobility Group Protein B1 Market Size Forecast by Region (2021-2026)
12.5 Latin America High Mobility Group Protein B1 Market Size Forecast (2021-2026)
12.5.1 Latin America: High Mobility Group Protein B1 Sales Forecast (2021-2026)
12.5.2 Latin America: High Mobility Group Protein B1 Revenue Forecast (2021-2026)
12.5.3 Latin America: High Mobility Group Protein B1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa High Mobility Group Protein B1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: High Mobility Group Protein B1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: High Mobility Group Protein B1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: High Mobility Group Protein B1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key High Mobility Group Protein B1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 High Mobility Group Protein B1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. High Mobility Group Protein B1 Market Segments
Table 2. Ranking of Global Top High Mobility Group Protein B1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global High Mobility Group Protein B1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Dociparstat Sodium
Table 5. Major Manufacturers of RBM-005
Table 6. Major Manufacturers of EV-007156
Table 7. Major Manufacturers of Others
Table 8. Global High Mobility Group Protein B1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global High Mobility Group Protein B1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global High Mobility Group Protein B1 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global High Mobility Group Protein B1 Sales Market Share by Regions (2015-2020)
Table 12. Global High Mobility Group Protein B1 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global High Mobility Group Protein B1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global High Mobility Group Protein B1 Sales Share by Manufacturers (2015-2020)
Table 15. Global High Mobility Group Protein B1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global High Mobility Group Protein B1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Mobility Group Protein B1 as of 2019)
Table 17. High Mobility Group Protein B1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. High Mobility Group Protein B1 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers High Mobility Group Protein B1 Price (2015-2020) (USD/Pcs)
Table 20. High Mobility Group Protein B1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers High Mobility Group Protein B1 Product Type
Table 22. Date of International Manufacturers Enter into High Mobility Group Protein B1 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global High Mobility Group Protein B1 Sales by Type (2015-2020) (K Pcs)
Table 25. Global High Mobility Group Protein B1 Sales Share by Type (2015-2020)
Table 26. Global High Mobility Group Protein B1 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global High Mobility Group Protein B1 Revenue Share by Type (2015-2020)
Table 28. High Mobility Group Protein B1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global High Mobility Group Protein B1 Sales by Application (2015-2020) (K Pcs)
Table 30. Global High Mobility Group Protein B1 Sales Share by Application (2015-2020)
Table 31. North America High Mobility Group Protein B1 Sales by Country (2015-2020) (K Pcs)
Table 32. North America High Mobility Group Protein B1 Sales Market Share by Country (2015-2020)
Table 33. North America High Mobility Group Protein B1 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America High Mobility Group Protein B1 Revenue Market Share by Country (2015-2020)
Table 35. North America High Mobility Group Protein B1 Sales by Type (2015-2020) (K Pcs)
Table 36. North America High Mobility Group Protein B1 Sales Market Share by Type (2015-2020)
Table 37. North America High Mobility Group Protein B1 Sales by Application (2015-2020) (K Pcs)
Table 38. North America High Mobility Group Protein B1 Sales Market Share by Application (2015-2020)
Table 39. Europe High Mobility Group Protein B1 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe High Mobility Group Protein B1 Sales Market Share by Country (2015-2020)
Table 41. Europe High Mobility Group Protein B1 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe High Mobility Group Protein B1 Revenue Market Share by Country (2015-2020)
Table 43. Europe High Mobility Group Protein B1 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe High Mobility Group Protein B1 Sales Market Share by Type (2015-2020)
Table 45. Europe High Mobility Group Protein B1 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe High Mobility Group Protein B1 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific High Mobility Group Protein B1 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific High Mobility Group Protein B1 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific High Mobility Group Protein B1 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific High Mobility Group Protein B1 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific High Mobility Group Protein B1 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific High Mobility Group Protein B1 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific High Mobility Group Protein B1 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific High Mobility Group Protein B1 Sales Market Share by Application (2015-2020)
Table 55. Latin America High Mobility Group Protein B1 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America High Mobility Group Protein B1 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa High Mobility Group Protein B1 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America High Mobility Group Protein B1 Revenue Market Share by Country (2015-2020)
Table 59. Latin America High Mobility Group Protein B1 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America High Mobility Group Protein B1 Sales Market Share by Type (2015-2020)
Table 61. Latin America High Mobility Group Protein B1 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America High Mobility Group Protein B1 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa High Mobility Group Protein B1 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa High Mobility Group Protein B1 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa High Mobility Group Protein B1 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa High Mobility Group Protein B1 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa High Mobility Group Protein B1 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa High Mobility Group Protein B1 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa High Mobility Group Protein B1 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa High Mobility Group Protein B1 Sales Market Share by Application (2015-2020)
Table 71. Affibody AB Corporation Information
Table 72. Affibody AB Description and Major Businesses
Table 73. Affibody AB High Mobility Group Protein B1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Affibody AB Product
Table 75. Affibody AB Recent Development
Table 76. Cantex Pharmaceuticals Inc Corporation Information
Table 77. Cantex Pharmaceuticals Inc Description and Major Businesses
Table 78. Cantex Pharmaceuticals Inc High Mobility Group Protein B1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Cantex Pharmaceuticals Inc Product
Table 80. Cantex Pharmaceuticals Inc Recent Development
Table 81. Dicerna Pharmaceuticals Inc Corporation Information
Table 82. Dicerna Pharmaceuticals Inc Description and Major Businesses
Table 83. Dicerna Pharmaceuticals Inc High Mobility Group Protein B1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Dicerna Pharmaceuticals Inc Product
Table 85. Dicerna Pharmaceuticals Inc Recent Development
Table 86. Evec Inc Corporation Information
Table 87. Evec Inc Description and Major Businesses
Table 88. Evec Inc High Mobility Group Protein B1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Evec Inc Product
Table 90. Evec Inc Recent Development
Table 91. Ribomic Inc Corporation Information
Table 92. Ribomic Inc Description and Major Businesses
Table 93. Ribomic Inc High Mobility Group Protein B1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Ribomic Inc Product
Table 95. Ribomic Inc Recent Development
Table 96. Global High Mobility Group Protein B1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global High Mobility Group Protein B1 Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global High Mobility Group Protein B1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global High Mobility Group Protein B1 Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: High Mobility Group Protein B1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: High Mobility Group Protein B1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: High Mobility Group Protein B1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: High Mobility Group Protein B1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: High Mobility Group Protein B1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: High Mobility Group Protein B1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: High Mobility Group Protein B1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: High Mobility Group Protein B1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: High Mobility Group Protein B1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: High Mobility Group Protein B1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key High Mobility Group Protein B1 Players
Table 114. High Mobility Group Protein B1 Customers List
Table 115. High Mobility Group Protein B1 Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. High Mobility Group Protein B1 Product Picture
Figure 2. Global High Mobility Group Protein B1 Sales Market Share by Type in 2020 & 2026
Figure 3. Dociparstat Sodium Product Picture
Figure 4. RBM-005 Product Picture
Figure 5. EV-007156 Product Picture
Figure 6. Others Product Picture
Figure 7. Global High Mobility Group Protein B1 Sales Market Share by Application in 2020 & 2026
Figure 8. Autoimmune Disorders
Figure 9. Cerebral Infarction
Figure 10. Chemotherapy Effects
Figure 11. Others
Figure 12. High Mobility Group Protein B1 Report Years Considered
Figure 13. Global High Mobility Group Protein B1 Market Size 2015-2026 (US$ Million)
Figure 14. Global High Mobility Group Protein B1 Sales 2015-2026 (K Pcs)
Figure 15. Global High Mobility Group Protein B1 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global High Mobility Group Protein B1 Sales Market Share by Region (2015-2020)
Figure 17. Global High Mobility Group Protein B1 Sales Market Share by Region in 2019
Figure 18. Global High Mobility Group Protein B1 Revenue Market Share by Region (2015-2020)
Figure 19. Global High Mobility Group Protein B1 Revenue Market Share by Region in 2019
Figure 20. Global High Mobility Group Protein B1 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by High Mobility Group Protein B1 Revenue in 2019
Figure 22. High Mobility Group Protein B1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global High Mobility Group Protein B1 Sales Market Share by Type (2015-2020)
Figure 24. Global High Mobility Group Protein B1 Sales Market Share by Type in 2019
Figure 25. Global High Mobility Group Protein B1 Revenue Market Share by Type (2015-2020)
Figure 26. Global High Mobility Group Protein B1 Revenue Market Share by Type in 2019
Figure 27. Global High Mobility Group Protein B1 Market Share by Price Range (2015-2020)
Figure 28. Global High Mobility Group Protein B1 Sales Market Share by Application (2015-2020)
Figure 29. Global High Mobility Group Protein B1 Sales Market Share by Application in 2019
Figure 30. Global High Mobility Group Protein B1 Revenue Market Share by Application (2015-2020)
Figure 31. Global High Mobility Group Protein B1 Revenue Market Share by Application in 2019
Figure 32. North America High Mobility Group Protein B1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America High Mobility Group Protein B1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America High Mobility Group Protein B1 Sales Market Share by Country in 2019
Figure 35. North America High Mobility Group Protein B1 Revenue Market Share by Country in 2019
Figure 36. U.S. High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America High Mobility Group Protein B1 Market Share by Type in 2019
Figure 41. North America High Mobility Group Protein B1 Market Share by Application in 2019
Figure 42. Europe High Mobility Group Protein B1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe High Mobility Group Protein B1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe High Mobility Group Protein B1 Sales Market Share by Country in 2019
Figure 45. Europe High Mobility Group Protein B1 Revenue Market Share by Country in 2019
Figure 46. Germany High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe High Mobility Group Protein B1 Market Share by Type in 2019
Figure 57. Europe High Mobility Group Protein B1 Market Share by Application in 2019
Figure 58. Asia Pacific High Mobility Group Protein B1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific High Mobility Group Protein B1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific High Mobility Group Protein B1 Sales Market Share by Region in 2019
Figure 61. Asia Pacific High Mobility Group Protein B1 Revenue Market Share by Region in 2019
Figure 62. China High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific High Mobility Group Protein B1 Market Share by Type in 2019
Figure 85. Asia Pacific High Mobility Group Protein B1 Market Share by Application in 2019
Figure 86. Latin America High Mobility Group Protein B1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America High Mobility Group Protein B1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America High Mobility Group Protein B1 Sales Market Share by Country in 2019
Figure 89. Latin America High Mobility Group Protein B1 Revenue Market Share by Country in 2019
Figure 90. Mexico High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America High Mobility Group Protein B1 Market Share by Type in 2019
Figure 97. Latin America High Mobility Group Protein B1 Market Share by Application in 2019
Figure 98. Middle East and Africa High Mobility Group Protein B1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa High Mobility Group Protein B1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa High Mobility Group Protein B1 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa High Mobility Group Protein B1 Revenue Market Share by Country in 2019
Figure 102. Turkey High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E High Mobility Group Protein B1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E High Mobility Group Protein B1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa High Mobility Group Protein B1 Market Share by Type in 2019
Figure 109. Middle East and Africa High Mobility Group Protein B1 Market Share by Application in 2019
Figure 110. North America High Mobility Group Protein B1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America High Mobility Group Protein B1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe High Mobility Group Protein B1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe High Mobility Group Protein B1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific High Mobility Group Protein B1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific High Mobility Group Protein B1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America High Mobility Group Protein B1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America High Mobility Group Protein B1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa High Mobility Group Protein B1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa High Mobility Group Protein B1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed


【掲載企業】

Affibody AB、Cantex Pharmaceuticals Inc、Dicerna Pharmaceuticals Inc、Evec Inc、Ribomic Inc

★調査レポート[世界の高移動度群タンパク質B1市場インサイト及び予測(~2026年)] (コード:QYR20NV01191)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の高移動度群タンパク質B1市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆